Evidence map›Paper›PMID 32924762›Full record

ArticleJournal of primary care & community health

Analysis of Glucose Levels in Patients Hospitalized With COVID-19 During the First Phase of This Pandemic in West Texas.

Sanjana Rao, Kiran Ali, Jeff Dennis, Gilbert Berdine, Victor Test, Kenneth Nugent

Open access · goldAbstract read
In one paragraph

Article in Journal of primary care & community health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Mean Blood Glucose Level During ICU Hospitalization is a Strong Predictor of the Mortality of COVID-19.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Article
  5. Article
  6. Glucose variability is a marker for COVID-19 severity and mortality.Archives of endocrinology and metabolism · 2022
    Article
  7. Impact of COVID-19 on Kidney of Diabetic Patients.Medicina (Kaunas, Lithuania) · 2022
    Review
  8. Diabetic Ketoacidosis in Patients With COVID-19.The American journal of the medical sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sanjana RaoTexas Tech University Health Sciences Center, Lubbock, TX, USA.ORCID 0000-0002-1859-5749
Kiran AliTexas Tech University Health Sciences Center, Lubbock, TX, USA.
Jeff DennisTexas Tech University Health Sciences Center, Lubbock, TX, USA.ORCID 0000-0003-0264-3635
Gilbert BerdineTexas Tech University Health Sciences Center, Lubbock, TX, USA.
Victor TestTexas Tech University Health Sciences Center, Lubbock, TX, USA.
Kenneth NugentTexas Tech University Health Sciences Center, Lubbock, TX, USA.ORCID 0000-0003-2781-4816
Texas Tech University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with hyperglycemia during hospitalization, especially during ICU hospitalizations, often have worse outcomes, even if they do not have a premorbid diagnosis of diabetes. High glucose levels can provide insight into the underlying pathogenesis of a disease and can contribute to tissue injury. Some patients with COVID-19 have hyperglycemia during hospitalizations.

methodsThe Infectious Disease and Control office at University Medical Center in Lubbock, Texas, provided a list of patients with a COVID-19 infection hospitalized between March 1 and May 15, 2020. The medical records were reviewed to collect information on age, gender, history of diabetes, and glucose levels on admission and through the first 7 days of hospitalization.

resultsThis study included 63 patients with a mean age of 62.1 ± 14.1 years. Thirty-five patients (55.6%) were males. The in-hospital mortality rate was 30.2%. The mean admission glucose level was 129.4 ± 57.1 mg/dL in patients who survived (N = 47) and 189.6 ± 112.2 mg/dL in patients who died during hospitalization (N = 16,

conclusionsPatients who died during hospitalization for COVID-19 had higher admission glucose levels than patients who survived. Larger differences between maximum and minimum glucose levels during the first 7 days of hospitalization were associated with increased mortality. These results suggest that high glucose levels identify patients at increased risk for mortality and warrant more study.

Indexed as

PandemicsAgedBlood GlucoseCoronavirus InfectionsCOVID-19FemaleHospitalizationHumansHyperglycemiaMaleMiddle AgedPneumonia, ViralRisk AssessmentTexasTreatment OutcomeBlood GlucoseCOVID-19glucoseglucose variabilitymortalityoutcomes

Identifiers

PMID32924762
PMCPMC7493238
OpenAlexW3085606519

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.